HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitative Fundus Autofluorescence in Best Vitelliform Macular Dystrophy: RPE Lipofuscin is not Increased in Non-Lesion Areas of Retina.

Abstract
Since the lipofuscin of retinal pigment epithelial (RPE) cells has been implicated in the pathogenesis of Best vitelliform macular dystrophy, we quantified fundus autofluorescence (quantitative fundus autofluorescence, qAF) as an indirect measure of RPE lipofuscin levels. Mean non-lesion qAF was found to be within normal limits for age. By spectral domain optical coherence tomography (SD-OCT) vitelliform lesions presented as fluid-filled subretinal detachments containing reflective material. We discuss photoreceptor outer segment debris as the source of the intense fluorescence of these lesions and loss of anion channel functioning as an explanation for the bullous photoreceptor-RPE detachment. Unexplained is the propensity of the disease for central retina.
AuthorsJanet R Sparrow, Tobias Duncker, Russell Woods, François C Delori
JournalAdvances in experimental medicine and biology (Adv Exp Med Biol) Vol. 854 Pg. 285-90 ( 2016) ISSN: 0065-2598 [Print] United States
PMID26427423 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • BEST1 protein, human
  • Bestrophins
  • Chloride Channels
  • Eye Proteins
  • Lipofuscin
Topics
  • Bestrophins
  • Chloride Channels (genetics, metabolism)
  • Eye Proteins (genetics, metabolism)
  • Fluorescence
  • Fundus Oculi
  • Genetic Predisposition to Disease (genetics)
  • Humans
  • Lipofuscin (chemistry, metabolism)
  • Microscopy, Confocal (methods)
  • Mutation
  • Ophthalmoscopy (methods)
  • Retinal Pigment Epithelium (chemistry, metabolism, pathology)
  • Tomography, Optical Coherence (methods)
  • Vitelliform Macular Dystrophy (diagnosis, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: